Article Text

Download PDFPDF
Risk of pancreatic cancer in patients with cystic fibrosis
  1. P Maisonneuve1,
  2. B C Marshall2,
  3. A B Lowenfels3
  1. 1European Institute of Oncology, Milan, Italy
  2. 2The USA Cystic Fibrosis Foundation, Bethesda, USA
  3. 3New York Medical College, Valhalla, USA
  1. Correspondence to:
    Patrick Maisonneuve
    Division of Epidemiology and Biostatistics, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy; Patrick.Maisonneuve{at}ieo.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

About 5–10% of pancreatic cancers have been linked to an underlying genetic disorder, usually inherited in an autosomal dominant manner. We have previously studied the risk of cancer in patients with cystic fibrosis and found that, although the overall risk of cancer was not increased, there was a fivefold increase in the risk of digestive tract cancer.1,2 Because only four patients developed pancreatic cancer, it was difficult to estimate the risk accurately. Since the publication of these reports we have obtained information on additional patients with both cystic fibrosis and pancreatic cancer from the US cystic fibrosis patient registry, from published reports, and by querying surgeons, pathologists, and cystic fibrosis physicians in the USA, Canada, and Europe.

We now describe nine patients with cystic fibrosis and pancreatic cancer identified during the study period (1985 to 2006), including …

View Full Text

Footnotes

  • Conflict of interest: None declared.